References
- List A. F. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 1996; 10: 937–942
- Tattersall M. H.N., Ganeshaguru K., Hoffbrand A. V. Mechanisms of resistance of human acute leukemia cells to cytosine arabinoside. Br. J. Haematol. 1974; 27: 39–46
- Drahovsky D., Kreis W. Studies on drug resistance. II Kinase patterns in P815 neoplasm sensitive and resistant to 1-β-D-arabinofuranosylcytosine. Biochem. Pharmacol. 1970; 19: 940–944
- Bhalla K., Nayak R., Grant S. Isolation and Characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res. 1984; 44: 5029–5037
- Kees U. R., Ford J., Dawson V. M., Piall E., Aherne G. W. Development of resistance to 1-β-D-arabinofuranosyl cytosine after high-dose treatment in childhood lymphoblastic leukemia: Analysis of resistance mechanism in established cell lines. Cancer Res. 1989; 49: 3015–3019
- Steuart C D., Burke P. J. Cytidine deaminase and the development of resistance to arabinosyl cytosine. Natl. New. Biol. 1971; 233: 109–110
- Wiley J. S., Jones S. P., Sawyer W H., Paterson A. R.P. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J. Clin. Invest. 1982; 69: 479–487
- Rustum Y. M., Preisler H. D. Correlation between leukemic cell retention of 1-β-D-arabinofuranocylcytosine 5′-triphosphate and response to therapy. Cancer Res. 1979; 39: 42–49
- Kufe D. W., Major P. P., Egan E. M., Beardsley G. P. Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 1980; 255: 8997–9000
- Major P. P., Egan E. M., Beardsley G. P, Minden M. D., Kufe D. W. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc. Natl. Acad. Sci. USA 1981; 78: 3235–3239
- Leclerc J. M., Cheng Y. C. Demonstration of activities in leukemic cells capable of removing 1-β-D arabinofuranosyl cytosine (ara-C) from ara-C incorporated DNA. Proc. Am. Assoc. Cancer. Res. 1984; 25: 19
- Momparler R. L., Chu M. Y., Fischer G. A. Studies on a new mechanism of resistance of L5178 murine leukemia cells to cytosine arabinoside. Biochim. Biophys. Acta. 1968; 161: 481–493
- De Saintvincent B. R., Buttin G. Studies on 1-β-D arabinofuranosylcytosine resistant mutants of Chinese hamster fibroblasts IV. Altered regulation of dCTP synthetase generates arabinosylcytosine and thymidine resistance. Biochim. Biophys. Acta. 1980; 610: 352–359
- Tanaka M., Yoshida S. Altered sensitivity to 1-β-D-arabinofuranosylcytosine 5-triphosphate of DNA polymerase from leukemia blasts of acute lymphoblastic leukemia. Cancer Res. 1982; 42: 649–653
- Chottiner E. G., Shewach D. S., Datta N. S., Ashcraft E., Gribbin D., Ginsburg D., Fox I H., Mitchell B. S. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. USA 1991; 88: 1531–1535
- Kobayashi T., Kakihara T., Uchiyama M., Fukuda T., Kishi K., Shibata A. Low expression of deoxycytidine kinase(dCK) gene in a 1-β-D- arabinofuranosylcytosine-resistant human leukemic cell line KY- Ra. Leukemia and Lymphoma 1994; 15: 503–505
- Vanden Heuvel J. P., Tyson F. L., Bell D. A. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 1993; 14: 395–398
- Wawer C., Ruggeberg H., Meyer G., Muyzer G. A simple and rapid electrophoresis method to detect sequence variation in PCR-amplified DNA fragments. Nucleic Acids Res. 1995; 23: 4928–4929
- Owens J. K., Shewach D. S., Ullman B., Mitchell B. S. Resistance to 1-β-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res. 1992; 52: 2389–2393
- Flasshove M., Strumberg D., Ayscue L., Mitchell B. S., Tirier C., Heit W., Seeber S., Schutte J. Structural anlaysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia 1994; 8: 780–785
- Kolla S. S., Studzinski G. P. Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-β-arabino-furanosylcytosine. Cancer Res. 1994; 541: 1418–1421